Effectiveness of harmaline along with meglumine antimoniate on Leishmania major
Mahin Ghafourzadeh, Mohammad Mirzaie, Iraj Sharifi, Alireza Keyani, Ehsan Salarkia · 2026
Read Effectiveness of harmaline along with meglumine antimoniate on Leishmania major by Mahin Ghafourzadeh, Mohammad Mirzaie, Iraj Sharifi, Alireza Keyani, Ehsan Salarkia (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13504214.txt.
Description
Mahin Ghafourzadeh leads a team testing a plant compound alongside the standard drug for a skin form of leishmaniasis, in a 2026 study. The disease, spread by sandflies, affects millions, and the standard antimony drug is costly, slow, and toxic to heart, liver, and kidneys. Harmaline comes from a regional plant long used in folk care.
Computer docking showed harmaline grips two cell-death proteins, one more strongly than the other, which fits a kill switch for the parasite. In lab tests the compound alone slowed both parasite stages, and the mix with the standard drug worked better still. The mix showed no toxicity in safety checks. Death profiles pointed to a programmed death path in the parasite. The authors propose the pair as a candidate therapy.
Catalog record
| CREATOR | Mahin Ghafourzadeh, Mohammad Mirzaie, Iraj Sharifi, Alireza Keyani, Ehsan Salarkia |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26086 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |